Laboratorios Farmaceuticos Rovi, S.A.
OTC: LABFF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Juan Lopez-Belmonte Encina
- Employees
- 2,197
- Headquarters
- Madrid, Spain
- IPO year
- 2021
- Market cap
- $4.6B
- Website
- https://www.rovi.es
Loading LABFF…
Loading profile data…Frequently asked questions about LABFF
What does Laboratorios Farmaceuticos Rovi, S.A. (LABFF) do?
Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical firm actively involved in the discovery, creation, manufacturing, and commercialization of medicinal products. Its market presence extends across Spain, the European Union, OECD nations, and other international territories. Beyond its proprietary portfolio, Rovi also distributes pharmaceu...
Where does LABFF trade?
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) trades on the Other OTC.
What sector is LABFF in?
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Laboratorios Farmaceuticos Rovi, S.A.?
Juan Lopez-Belmonte Encina is the chief executive officer of Laboratorios Farmaceuticos Rovi, S.A. (LABFF).
Where is Laboratorios Farmaceuticos Rovi, S.A. headquartered?
Laboratorios Farmaceuticos Rovi, S.A. is headquartered in Spain.
Does LABFF pay a dividend?
Yes — Laboratorios Farmaceuticos Rovi, S.A. (LABFF) paid a trailing twelve-month dividend of USD 1.09 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did LABFF go public?
Laboratorios Farmaceuticos Rovi, S.A. (LABFF) completed its initial public offering in 2021.